S7 E12: Nasal Sprays vs URTI Redux; Orforglipron vs Dapa; Hypnotherapy in Kids; Interview with Dr Liz Bancroft and Natalia Norori on Prostate Cancer Screening with BRCA2
NO
PHARMACEUTICAL INFLUENCE
10th July 2026
If you are having difficulties listening to this Podcast, try to play this episode in Spotify
Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. In this episode, we have three new pieces of research and a special interview later on discussing the recommendations of the National Screening Committee on prostate cancer screening in the UK.
First up for research: nasal sprays versus the common cold. The BJGP reports on longer-term findings through this simple intervention. Can it help this age-old problem?
Second, new kid on the block, orforglipron - could it replace SGLT2 inhibitors for management of type 2 diabetes?
Third, home-based hypnotherapy. Can it help children struggling with functional abdominal pain or IBS? We have a RCT to tell us.
Finally, our interview with Dr Liz Bancroft, consultant nurse in oncogentics research, and Natalia Norori, interim Head of Data and Evidence at Prostate Cancer UK join us to discuss the new recommendations from the National Screening Programme with targeted screening of men with BRCA2, why they made this recommendation and how this affects us in general practice, plus what we need to know for our patients about the government-backed trial, TRANSFORM.
References
Prostate Cancer UK Information on NSC decision
Prostate Cancer UK Health Professional NSC FAQs
National Screening Committee report on prostate cancer screening
BJGP Nasal sprays for the common cold
Lancet Nasal Sprays original paper
Lancet Orforglipron vs dapagliflozin and T2DM
BJGP Hypnotherapy in children for abdo pain
National Screening Committee report on prostate cancer screening
Join us at one of our upcoming courses or live webinars
